The present studies were performed to characterize the molecular form(s) of sometostatin present in the myenteric plexus and to examine some aspects of the regulatory mechanisms underlying somatostatin release and somatostatin-induced release of acetyk9toline from this tissue. We observed the following: (1) ~a~~tin-like irnrnu~~~~ (SU) is present in the myenteric plexus of the guinea pig ileum with somatostatiri-I 4 being the predominant molecular form. (2) 
S
OMATOSTAT'IN-LIKE immunoreactivity (SLI) is widely distributed in the enteric nervous system in a population of interneurons' and serves to regulate the release of neurotransmitters2 The moiecular form(s) of somatostatin present in the myenteric plexus are unknown.
Somatostatin can stimulate or inhibit ~stroint~tin~ motility depending on the experimentai conditions.3*4 This may be associated with its ability to stimulate acetylcholine release under basal conditions while the peptide inhibits the release of this transmitter under stimulated conditions.' Somatostatin appears to inhibit acetylcholine release by activating a pertussis toxin @'TX)-sensitive guanine nucleotide binding protein (Gi/Go) coupled to cyclic adenosine monophosphate (cAMP)-dependent cholinergic transmission6 However, neither the regulation of somatostatin release nor somatostatinmediated release of acetylcholine is well understood.
Neurosecretion is associated with calcium entry into the ceh via vol~gede~ndent calcium channels7 Three types of calcium channels have been described on vertebrate neurons, designated T, L, and N, which differ in their electrophysiological properties and response to application of pharmacological agents.* It has been suggested that the calcium channel subtypes may be preferentially associated with release of different neurot~smitte~~.'"
The goals of these studies were twofold: (1) To characterize the molecular species of somatostatin present in the myenteric plexus; and (2) To examine the regulation of somatostatin release and somatostatin-mediated release of acetylcholine.
MATERIALS AND METHODS

characterization of%1
Isolated strips of guinea pig ileal longitudinal muscle-myenteric plexus were prepared as described previously." Somatostatin-like immunoreactivity was characterized using the methods of Yamada et ai.12 Briefly, the tissue strips were initially boiled in 3% acetic acid. The extract was placed on Sephadex GSO (Pharmacia, Piscataway, NJ) supertine cohtmns (1 X 120 cm) and duted with 0.1 mol/L ammonium acetate, pH 5.0 to separate the molecular forms of somatostatin. Somatostatin-like immunoreactivity was measured by radioimmunoassay using antibody 100 I, which is specific for the central ring portion of the molecule.
Release of SLI From Dissociated Myenteric Cknglia
Isolated ganglia from the guinea pig ileum myenteric plexus were prepared as described previously." Approximately 200 ganglia were Membdlrsm, Vol39, No 9. Sup@2 (September), 1990: pp 1 S 1-q 33 placed in each of several chambers and perfused with Krebs buffer under standard conditions at 1 ml/mitt. Samples were collected at 2-minute intervals and assayed for SLI. The ganglia were exposed to the depolarizing agents veratridine (100 rmoi/L) or the gangfionic agonist ~methylphenylpi~~inium (DMPP, 100 gmol/L) for 4 minutes after a 30-minute basal collection period. This was followed by an additional 30-minute collection period. Calcium channel antagonists nitrendipine (L channel blocker, 10 pmol/L) and cadmium (nonselective calcium channel blocker at 500 pmol/L) were added to the pet&sate 4 minutes before and during the depolarization period. Some tissue samples were pretreated with wconotoxin (N and L channel blocker, IO pmol/L) for I hour prior to &~nning the perfusion studies. For experiments designed to examine the question of whether somatostatin regulates its own release, (L~u~-D-T~~~~-T~?~) S28, a nonimmunoreactive but biologically active analog of somatostatin (S28a, I rmol/L) was added to the perfusate 4 minutes before and during the depolarization period."' Some experiments were performed aher pretreating the tissue for 3 hours with PTX (200 ng/ mL). This agent inactivates the i~~to~ guanine nucleotide binding proteins (Gi/Gof that are coupled to adenylate cycIase.t5
E$et of Somatostatin on the Release of 'H-Acetylcholine
From Myenteric Ganglia
Approximately 200 ganglii per perfusion chamber were prepared from the guinea pi8 ileum myenteric plexus and labeled with 3H-acetylcholine for 40 minutes as described previously.t3 The labeled ganglia were perfiised at 1 mL/min with Kmbs buffer maintained under standard conditions. Samples were collected as described above. Randomized concentrations of somatostatin-I4 were added to the perfusate for 4 minutes following a 30-minute basal collection period. This was followed by an additional 30-minute collection period. Calcium channel blockers were added to the perfusate as described above. Tritium radioactivity released during each collection period was counted in a liquid scintillation spectrometer. Assessment of what percent of the labeled metabolites was in the form of 'H-acetylcholine was performed on ion exchange columns as described previously. '6 We observed that more than 85% of the labeled metabolites of choline was in the form of 3H-acetylcholine during stimulated conditions. Pharmacological studies involving potassium-evoked transmitter release from cultured neurons suggest that N channels may be preferenti~ly associated with norepinephrine release from sym~thetic neurons while caicium entry via L channels is associated with release of substance P from dorsal root ganglion neurons.9"o We examined the effect of calcium channel blockers on DMPP-induced release of somatostatin and somatostatin-evoked release of acetylcholine from myenteric plexus ganglia. DMPP stimulated significant
RESULTS AND DISCUSSION
We observed that somatostatin-14 is the predominant molecular species of the peptide present in the guinea pig ileum myenteric plexus. The elution profile of somatostatin extracted from longitudinal muscle-myenteric plexus preparations from this region is shown in Fig 1. A smaller peak that coeluted with somatostatin-28 was also detected. These results are similar to those reported previously describing the molecular forms of somatostatin present in the gastric mucosa release of somatostatin that was unaffected by the L channel antagonist nitrendipine but inhibited 48% + 4% and 88% + 3% (n = 4, P -c .05) by the combined N and L channel antagonist w-conotoxin and nonselective calcium channel blocker cadmium (500 pmol/L), respectively. The results are presented in Fig 3. These observations confirm that neurosecretion of somatostatin is calciumdependent and suggest that calcium entry via N channels is preferentially associated with release of somatostatin from myenteric plexus ganglia. Somatostatin-14 produced concentration-dependent release of 3H-acetylcholine that is shown in Fig 4. Somatostatin-induced release of acetylcholine was significantly inhibited 56% + 5%, 46 + 8%, and 82% + 4% (n = 4, P c .05) by nitrendipine, w-conotoxin, and cadmium, respectively. The results of these studies are presented in Fig 5. Thus, in contrast to the situation with DMPP-induced somatostatin release, calcium entry via the L channel plays an important role in somatostatin-evoked release of acetylcholine from myenteric ganglia.
